查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
成像市場報告：至2030年的趨勢、預測與競爭分析
市場調查報告書
商品編碼
1356934

成像市場報告：至2030年的趨勢、預測與競爭分析

Bio-Imaging Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

成像趨勢和預測

預計到2030年，全球成像市場將達到 170 億美元，2024年至2030年年複合成長率為 15.7%。該市場的主要驅動力是由於成像技術的進步、慢性病患病率上升和世界人口高齡化、診斷中心數量增加和放射性藥物數量增加而對成像設備的需求增加。全球成像市場的未來充滿希望，診所、診斷中心、醫院和實驗室市場都有商機。

成像市場洞察

  • Lucintel 預測，由於 X光照相術在急診醫學、整形外科和普通放射學中的應用不斷增加，預計在預測期內將實現最高成長。
  • 在這個市場中，由於基礎設施和先進影像處理設備的重大發展使醫院業務，醫院將繼續成為最大的細分市場。
  • 由於其完善的醫療保健系統、先進的醫療設施、不斷增加的心臟疾病發病率以及較高的健康保險普及，預計北美在預測期內仍將是最大的地區，尤其是在美國。

本報告回答了 11 個關鍵問題：

  • Q.1.細分市場中最有前途和高成長的機會為何？
  • Q.2.哪個細分市場將以更快的速度成長？理由為何？
  • Q.3.哪些地區未來會出現更快的成長？理由為何？
  • Q.4.影響市場動態的主要因素有哪些？市場的主要挑戰和商業風險是什麼？
  • Q.5.這個市場的商業風險和競爭威脅為何？
  • Q.6.這個市場有哪些新趨勢？理由為何？
  • Q.7.市場客戶需求有何改變？
  • Q.8.該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10.該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球成像市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球成像市場趨勢（2018-2023）與預測（2024-2030）
  • 全球成像市場，依類型
    • 彈性成像
    • 磁振造影
    • 醫學超音波或超音波檢查
    • X光攝影
  • 依技術分類的全球成像市場
    • 醫學
    • 分子
  • 全球成像市場，依最終用途
    • 診所
    • 診斷中心
    • 醫院
    • 實驗室

第4章 2018-2030年市場趨勢及預測分析，依地區

  • 全球成像市場區域分佈
  • 北美成像市場
  • 歐洲成像市場
  • 亞太生物成像市場
  • 其他區域成像市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球成像市場成長機會，依類型
    • 全球成像市場成長機會，依技術
    • 全球成像市場成長機會，依最終用途
    • 全球成像市場成長機會，依地區
  • 全球成像市場新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球成像市場的產能
    • 全球成像市場的合併、收購和合資企業
    • 認證和許可

第7章 主要企業概況

  • Bioclinica
  • Bracco Imaging
  • FONAR
  • Bayer Healthcare Pharmaceuticals
  • Covidin corp
  • GE Healthcare
  • GammaMedica
簡介目錄

Bio-Imaging Trends and Forecast

The future of the global bio-imaging market looks promising with opportunities in the clinic, diagnostic center, hospital, and laboratory markets. The global bio-imaging market is expected to reach an estimated $17.0 billion by 2030 with a CAGR of 15.7% from 2024 to 2030. The major drivers for this market are increasing demand of bio imaging instrument as an advancements in the imaging technologies, rising prevalence of chronic diseases and aging world population, and increasing number of diagnostic centers and radiopharmaceuticals.

A more than 150-page report is developed to help in your business decisions.

Bio-Imaging by Segment

The study includes a forecast for the global bio-imaging by type, technology, end use, and region.

Bio-Imaging Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Elastography
  • Magnetic Resonance Imaging
  • Medical Ultrasonography or Ultrasound
  • X-Ray Radiography

Bio-Imaging Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • Medical
  • Molecular

Bio-Imaging Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Clinics
  • Diagnostic Centers
  • Hospitals
  • Laboratories

Bio-Imaging Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Bio-Imaging Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies bio-imaging companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the bio-imaging companies profiled in this report include-

  • Bioclinica
  • Bracco Imaging
  • Fonar
  • Bayer Healthcare Pharmaceuticals
  • Covidin
  • GE Healthcare
  • Gammamedica

Bio-Imaging Market Insights

  • Lucintel forecasts that X-ray radiography is expected to witness highest growth over the forecast period due to its increasing adoption of emergency medicine, orthopedics, and general radiology.
  • Within this market, hospitals will remain the largest segment due to significantly growing developed infrastructure and advanced imaging facilities that enables hospitals to streamline their operations.
  • North America will remain the largest region during the forecast period due to presence of well-established healthcare systems, sophisticated medical facilities, increasing incidence of cancer and cardic diseases, and high adoption of healthcare insurance policies among the population particularly in the USA.

Features of the Global Bio-Imaging Market

  • Market Size Estimates: Bio-imaging market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
  • Segmentation Analysis: Bio-imaging market size by type, technology, end use, and region. in terms of value ($B).
  • Regional Analysis: Bio-imaging market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different types, technologies, end uses, and region.s for the bio-imaging market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the bio-imaging market.
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the bio-imaging market size?

Answer: The global bio-imaging market is expected to reach an estimated $17.0 billion by 2030.

Q.2. What is the growth forecast for bio-imaging market?

Answer: The global bio-imaging market is expected to grow with a CAGR of 15.7% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the bio-imaging market?

Answer: The major drivers for this market are increasing demand of bio imaging instrument as an advancements in the imaging technologies, rising prevalence of chronic diseases and aging world population, and increasing number of diagnostic centers and radiopharmaceuticals.

Q.4. What are the major segments for bio-imaging market?

Answer: The future of the bio-imaging market looks promising with opportunities in the clinic, diagnostic center, hospital, and laboratory markets.

Q.5. Who are the key bio-imaging market companies?

Answer: Some of the key bio-imaging companies are as follows:

  • Bioclinica
  • Bracco Imaging
  • Fonar
  • Bayer Healthcare Pharmaceuticals
  • Covidin
  • GE Healthcare
  • Gammamedica

Q.6. Which bio-imaging market segment will be the largest in future?

Answer: Lucintel forecasts that X-ray radiography is expected to witness highest growth over the forecast period due to its increasing adoption of emergency medicine, orthopedics, and general radiology.

Q.7. In bio-imaging market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region during the forecast period due to presence of well-established healthcare systems, sophisticated medical facilities, increasing incidence of cancer and cardic diseases, and high adoption of healthcare insurance policies among the population particularly in the USA.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the bio-imaging market by type (elastography, magnetic resonance imaging, medical ultrasonography or ultrasound, and X-ray radiography), technology (medical and molecular), end use (clinics, diagnostic centers, hospitals, and laboratories), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Bio-Imaging Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Bio-Imaging Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Bio-Imaging Market by Type
    • 3.3.1: Elastography
    • 3.3.2: Magnetic Resonance Imaging
    • 3.3.3: Medical Ultrasonography or Ultrasound
    • 3.3.4: X-ray Radiography
  • 3.4: Global Bio-Imaging Market by Technology
    • 3.4.1: Medical
    • 3.4.2: Molecular
  • 3.5: Global Bio-Imaging Market by End Use
    • 3.5.1: Clinics
    • 3.5.2: Diagnostic Centers
    • 3.5.3: Hospitals
    • 3.5.4: Laboratories

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Bio-Imaging Market by Region
  • 4.2: North American Bio-Imaging Market
    • 4.2.2: North American Bio-Imaging Market by End Use: Clinics, Diagnostic Centers, Hospitals, and Laboratories
  • 4.3: European Bio-Imaging Market
    • 4.3.1: European Bio-Imaging Market by Type: Elastography, Magnetic Resonance Imaging, Medical Ultrasonography or Ultrasound, and X-ray Radiography
    • 4.3.2: European Bio-Imaging Market by End Use: Clinics, Diagnostic Centers, Hospitals, and Laboratories
  • 4.4: APAC Bio-Imaging Market
    • 4.4.1: APAC Bio-Imaging Market by Type: Elastography, Magnetic Resonance Imaging, Medical Ultrasonography or Ultrasound, and X-ray Radiography
    • 4.4.2: APAC Bio-Imaging Market by End Use: Clinics, Diagnostic Centers, Hospitals, and Laboratories
  • 4.5: ROW Bio-Imaging Market
    • 4.5.1: ROW Bio-Imaging Market by Type: Elastography, Magnetic Resonance Imaging, Medical Ultrasonography or Ultrasound, and X-ray Radiography
    • 4.5.2: ROW Bio-Imaging Market by End Use: Clinics, Diagnostic Centers, Hospitals, and Laboratories

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Bio-Imaging Market by Type
    • 6.1.2: Growth Opportunities for the Global Bio-Imaging Market by Technology
    • 6.1.3: Growth Opportunities for the Global Bio-Imaging Market by End Use
    • 6.1.4: Growth Opportunities for the Global Bio-Imaging Market by Region
  • 6.2: Emerging Trends in the Global Bio-Imaging Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Bio-Imaging Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Bio-Imaging Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Bioclinica
  • 7.2: Bracco Imaging
  • 7.3: FONAR
  • 7.4: Bayer Healthcare Pharmaceuticals
  • 7.5: Covidin corp
  • 7.6: GE Healthcare
  • 7.7: GammaMedica